Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainKelch-typ_b-propeller

GAN KLHL7 CCIN

2.38e-0455413IPR015915
DomainKelch

GAN KLHL7 CCIN

2.79e-0458413SM00612
DomainBACK

GAN KLHL7 CCIN

3.08e-0460413SM00875
DomainBACK

GAN KLHL7 CCIN

3.23e-0461413PF07707
DomainBACK

GAN KLHL7 CCIN

3.23e-0461413IPR011705
DomainGrowth_fac_rcpt_

FBN2 HTRA4 UMODL1 ELAPOR1

3.73e-04156414IPR009030
DomainKelch_1

GAN KLHL7 CCIN

4.85e-0470413PF01344
DomainKelch_1

GAN KLHL7 CCIN

4.85e-0470413IPR006652
DomainZP_dom

ENG UMODL1

6.26e-0417412IPR001507
DomainZona_pellucida

ENG UMODL1

6.26e-0417412PF00100
DomainHAD-like_dom

ATP9B ATP1A1 PMM1

6.92e-0479413IPR023214
DomainEGF-like_dom

LAMA2 FBN2 C8B UMODL1

2.12e-03249414IPR000742
Domain-

ATP9B ATP1A1

2.24e-03324123.40.1110.10
Domain-

ATP9B ATP1A1

2.24e-03324122.70.150.10
DomainEGF_1

LAMA2 FBN2 C8B UMODL1

2.31e-03255414PS00022
DomainEGF-like_CS

LAMA2 FBN2 C8B UMODL1

2.51e-03261414IPR013032
DomainGal_Oxidase_b-propeller

GAN CCIN

2.52e-0334412IPR015916
DomainEGF_2

LAMA2 FBN2 C8B UMODL1

2.66e-03265414PS01186
DomainATPase_P-typ_cyto_domN

ATP9B ATP1A1

2.67e-0335412IPR023299
DomainP_typ_ATPase

ATP9B ATP1A1

2.83e-0336412IPR001757
DomainATPase_P-typ_P_site

ATP9B ATP1A1

2.83e-0336412IPR018303
DomainATPASE_E1_E2

ATP9B ATP1A1

2.83e-0336412PS00154
DomainBTB

GAN KLHL7 CCIN

2.96e-03131413PF00651
DomainATPase_P-typ_transduc_dom_A

ATP9B ATP1A1

2.98e-0337412IPR008250
DomainE1-E2_ATPase

ATP9B ATP1A1

2.98e-0337412PF00122
DomainGDS_CDC24_CS

TRIO ARHGEF10

3.31e-0339412IPR001331
DomainBTB-kelch_protein

GAN KLHL7

4.01e-0343412IPR017096
Domain-

GAN KLHL7

4.98e-03484122.120.10.80
DomainBTB

GAN KLHL7 CCIN

5.18e-03160413PS50097
Pubmed

Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin.

FLT1 ENG

1.42e-06242223437230
Pubmed

Early anti-angiogenic proteins expression in amniotic fluid of twin fetuses.

FLT1 ENG

1.42e-06242221962138
Pubmed

Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia.

FLT1 ENG

1.42e-06242219350449
Pubmed

Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.

FLT1 ENG

1.42e-06242223806447
Pubmed

Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule.

FLT1 ENG

1.42e-06242216870672
Pubmed

Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies.

FLT1 ENG

1.42e-06242218330824
Pubmed

Myocardial performance index in hypertensive disorders of pregnancy: The relationship between blood pressures and angiogenic factors.

FLT1 ENG

1.42e-06242228609171
Pubmed

Increased serum levels of anti-angiogenic factors soluble fms-like tyrosine kinase and soluble endoglin in sickle cell disease.

FLT1 ENG

1.42e-06242219039203
Pubmed

Uteroplacental arterio-venous difference in soluble VEGFR-1 (sFlt-1), but not in soluble endoglin concentrations in preeclampsia.

FLT1 ENG

1.42e-06242222264588
Pubmed

Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia.

FLT1 ENG

1.42e-06242224217170
Pubmed

Unexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluid.

FLT1 ENG

1.42e-06242220199197
Pubmed

Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia.

FLT1 ENG

1.42e-06242217210583
Pubmed

YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.

FLT1 ENG

1.42e-06242226159901
Pubmed

Correlations among antiangiogenic factors and trace elements in hypertensive disorders of pregnancy.

FLT1 ENG

1.42e-06242225053574
Pubmed

First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.

FLT1 ENG

1.42e-06242218771978
Pubmed

Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.

FLT1 ENG

4.27e-06342225979720
Pubmed

Independent risk factors for a small placenta and a small-for-gestational-age infant at 35-41 weeks of gestation: An association with circulating angiogenesis-related factor levels at 19-31 weeks of gestation.

FLT1 ENG

4.27e-06342228613009
Pubmed

Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage.

FLT1 ENG

4.27e-06342227664209
Pubmed

Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.

FLT1 ENG

4.27e-06342219412349
Pubmed

Maternal circulating angiogenic factors in twin and singleton pregnancies.

FLT1 ENG

4.27e-06342225434840
Pubmed

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.

FLT1 ENG

4.27e-06342220948996
Pubmed

A longitudinal analysis of angiotensin II type 1 receptor antibody and angiogenic markers in pregnancy.

FLT1 ENG

4.27e-06342227793555
Pubmed

Circulating angiogenic and antiangiogenic factors in women with eclampsia.

FLT1 ENG

4.27e-06342221062661
Pubmed

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.

FLT1 ENG

4.27e-06342218175241
Pubmed

Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery.

FLT1 ENG

4.27e-06342221939291
Pubmed

Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.

FLT1 ENG

4.27e-06342219165674
Pubmed

Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy.

FLT1 ENG

4.27e-06342227067718
Pubmed

Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes.

FLT1 ENG

4.27e-06342228121958
Pubmed

Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies.

FLT1 ENG

4.27e-06342219135290
Pubmed

Dysregulation of complement system in HELLP syndrome.

FLT1 ENG

4.27e-06342234697959
Pubmed

Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.

FLT1 ENG

4.27e-06342217956952
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

OSBPL10 ATXN2L CPNE6 ASRGL1 UQCRFS1 ATP1A1 TRIO RPL12 RAPGEF4 TPI1

5.95e-061431421037142655
Pubmed

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

FLT1 ENG

8.53e-06442221827221
Pubmed

The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia.

FLT1 ENG

8.53e-06442230177039
Pubmed

The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.

FLT1 ENG

8.53e-06442227169826
Pubmed

Correlations between circulating levels of adipokines and anti-angiogenic factors in women with BMI <30 and a late-onset preeclampsia.

FLT1 ENG

8.53e-06442224380505
Pubmed

Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.

FLT1 ENG

8.53e-06442221867402
Pubmed

Allelic variations in angiogenic pathway genes are associated with preeclampsia.

FLT1 ENG

2.13e-05642220223440
Pubmed

Distinct alpha 7A beta 1 and alpha 7B beta 1 integrin expression patterns during mouse development: alpha 7A is restricted to skeletal muscle but alpha 7B is expressed in striated muscle, vasculature, and nervous system.

LAMA2 ENG

2.98e-0574228950511
Pubmed

B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.

FLT1 ENG

2.98e-05742211986954
Pubmed

Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.

FLT1 HERC2 SLC6A19 RAPGEF4 ELAPOR1

8.27e-0537142515747579
Pubmed

The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.

ATXN2L HERC2 RFC5 TRIO

1.25e-0421242433853758
Pubmed

CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity.

ATXN2L ATP1A1 HERC2 RPL12 TPI1

1.44e-0441842535338135
Pubmed

Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli.

FLT1 ENG

1.48e-041542219087347
Pubmed

Identification of Thymosin β4 as an effector of Hand1-mediated vascular development.

FLT1 ENG

1.48e-041542220975697
Pubmed

RFWD3-Dependent Ubiquitination of RPA Regulates Repair at Stalled Replication Forks.

HERC2 RFC5

1.69e-041642226474068
Pubmed

Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis.

ATXN2L ATP1A1 IGLL5 RPL12

1.89e-0423642436339263
Pubmed

Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.

OSBPL10 ATXN2L VSIG8 UQCRFS1 ATP1A1 RFC5 RPL12 TPI1

2.00e-04136742832687490
Pubmed

Lymph sacs are not required for the initiation of lymph node formation.

FLT1 ENG

2.40e-041942219060331
Pubmed

PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

ATXN2L GAN ATP1A1 RPL12 TPI1

2.66e-0447742531300519
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

GAN FLT1 ATP1A1 RFC5 RAPGEF4

3.21e-0449742536774506
Pubmed

Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.

UQCRFS1 UMODL1 RPL12 PMM1

3.77e-0428342418854154
Pubmed

Genome-wide association study of periodontal health measured by probing depth in adults ages 18-49 years.

LAMA2 OSBPL10

3.86e-042442224347629
Pubmed

ARID3A is required for mammalian placenta development.

FLT1 ENG

5.28e-042842227965054
Pubmed

Extra-embryonic vasculature development is regulated by the transcription factor HAND1.

FLT1 ENG

5.28e-042842215073150
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

FBN2 ATP1A1 HERC2 RFC5 TRIO KLHL7

5.28e-0485342628718761
Pubmed

Dosage-dependent requirement for mouse Vezf1 in vascular system development.

FLT1 ENG

5.66e-042942215882861
Pubmed

Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.

LAMA2 FBN2 HERC2 GTPBP6 ARHGEF10 ZNF268 ZNF433

5.77e-04121542715146197
Pubmed

The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.

ATXN2L ATP1A1 RPL12

6.67e-0414142332322062
Pubmed

Chemical Crosslinking Mass Spectrometry Analysis of Protein Conformations and Supercomplexes in Heart Tissue.

LAMA2 UQCRFS1 ATP1A1 RPL12

6.78e-0433142429199018
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

ATXN2L GAN WDR75 RFC5 KLHL7 RPL12 TPI1

7.06e-04125742736526897
Pubmed

SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.

ATXN2L ATP1A1 HIBADH IGLL5 TPI1

7.95e-0460742539147351
Pubmed

Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.

ATXN2L HERC2 RFC5 RPL12 TPI1

9.12e-0462642533644029
Pubmed

Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.

ATXN2L ATP1A1 HIBADH RPL12 SLC6A19

1.01e-0364142536057605
Pubmed

Update on the Kelch-like (KLHL) gene family.

GAN KLHL7

1.13e-034142223676014
GeneFamilyBasic leucine zipper proteins|BTB domain containing

GAN KLHL7 CCIN

1.54e-03134313861
GeneFamilyReceptor Tyrosine Kinases|CD molecules

FLT1 LTK

2.13e-0340312321
GeneFamilyKelch like|BTB domain containing

GAN KLHL7

2.35e-0342312617
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

TRIO ARHGEF10

5.70e-0366312722
ToppCellAdult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor

FLT1 ASRGL1 ENG UMODL1 RAPGEF4

3.61e-071604150cfe130606af433b2aa90e0a20b6c44659dd6fd4
ToppCell368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells)

MFSD4A FLT1 PTP4A3 ASRGL1 RAPGEF4

6.46e-071804158ab16a0b9053bffc07b569a4f9e71749f56dde7e
ToppCell368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells)

MFSD4A FLT1 PTP4A3 ASRGL1 RAPGEF4

6.46e-07180415394cd465b88429b70eebb2957480dffcbc51cfe7
ToppCellCOVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type

MFSD4A FLT1 ASRGL1 ENG RAPGEF4

9.84e-07196415ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCellCOVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type

MFSD4A FLT1 ASRGL1 ENG RAPGEF4

1.01e-061974157e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCellTracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

FLT1 ASRGL1 LTK ENG RAPGEF4

1.09e-06200415746e8f61411f8e68b988152ab36561991f716a0a
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 LTK ENG RAPGEF4

1.37e-05159414d3f81ba22160568ccaa6d2b04ebfd30630f9a6db
ToppCellCOVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type

FLT1 ENG CCIN RAPGEF4

1.41e-051604140d4880f85565d8c540c94a8f8109147b3029279a
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FLT1 ASRGL1 ENG RAPGEF4

1.63e-05166414f7926ee266dcbf10df375cd921f1db5a2fa604f8
ToppCell390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|390C / Donor, Lineage, Cell class and subclass (all cells)

FLT1 LTK ARHGEF10 RAPGEF4

1.87e-051724146f302ed795767a9636081dc64373f8f039ea16d2
ToppCell390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|390C / Donor, Lineage, Cell class and subclass (all cells)

FLT1 LTK ARHGEF10 RAPGEF4

1.87e-05172414fd8097299fc05390b30afaa9e6c80b1f607c27aa
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 ASRGL1 ENG RAPGEF4

1.87e-05172414c056d44e2e130ceccadfcdceb192a7f095d779c8
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 LTK ENG RAPGEF4

1.91e-05173414afa6bb19df52541d8d17cbfac9cbdd18a5f3632d
ToppCell390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells)

FLT1 PTP4A3 ENG RAPGEF4

2.14e-05178414804ac3725c1f88e2212172bfb9aa01d97a735621
ToppCell390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells)

FLT1 PTP4A3 ENG RAPGEF4

2.14e-05178414ad6dc4a375664c919bd48c35c48a561fc5a7de8c
ToppCelldroplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 PTP4A3 ENG RAPGEF4

2.14e-0517841493ce73f8bcec63ebf86fabb546f88400e8f06465
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MFSD4A UQCRFS1 ATP1A1 HIBADH

2.24e-0518041440f79b4455dbd1c2720dc32d9d77c70f835cecb3
ToppCellCOVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations)

FLT1 ENG ARHGEF10 RAPGEF4

2.28e-0518141426eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FLT1 ASRGL1 ENG RAPGEF4

2.28e-051814142c660fcf0404c155955b67ab2958d6e6b0e30024
ToppCelldroplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MFSD4A ATP1A1 HTRA4 ELAPOR1

2.33e-05182414ccfee33de0faebbe69099d4ff3c3971f6a708b99
ToppCell5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

OSBPL10 FLT1 ENG RAPGEF4

2.44e-0518441497e97de52daaff8840f4ee76a94ba5e3f79de7ce
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor

FLT1 LTK ENG RAPGEF4

2.49e-0518541407f9f38f0739d7c830641723a38385550ac1ac92
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA2 C8B RAPGEF4 ELAPOR1

2.49e-051854144e40d3103ebf4a7066b7ce300b6ef700ba0e2863
ToppCelldroplet-Heart-nan-24m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 PTP4A3 ENG RAPGEF4

2.49e-0518541411a44006950f6ccade86a85d5f06696d2036ffde
ToppCellControl-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations)

FLT1 ENG ARHGEF10 RAPGEF4

2.54e-05186414c6075fe84226b370c5139066793844ad33ae2db1
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA2 C8B RAPGEF4 ELAPOR1

2.54e-0518641416092819e9148dfe64f07c737652b6e533e699f7
ToppCell343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

FLT1 PTP4A3 LTK RAPGEF4

2.54e-05186414080e56113b89138277a2bd2eabddfa6cd1a18b61
ToppCelldroplet-Heart-nan-24m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 PTP4A3 ENG RAPGEF4

2.54e-051864148b316bfed39b91c15d5ae28d9261eb057f113796
ToppCell343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

FLT1 PTP4A3 LTK RAPGEF4

2.54e-05186414dae6a98963c78bf7518ebab8dc02f173c3b0f7f7
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor

FLT1 LTK ENG RAPGEF4

2.65e-0518841402a62888e9db29d20133eeca1686d302545a39c9
ToppCellControl-Endothelial_cells|Control / group, cell type (main and fine annotations)

FLT1 ENG ARHGEF10 RAPGEF4

2.65e-051884143953b08abfea93468fc8d177bdb16ca7c6ffa1ab
ToppCellCOVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

FLT1 ASRGL1 ENG RAPGEF4

2.71e-05189414c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCellControl-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class

LAMA2 FLT1 ENG RAPGEF4

2.76e-051904147f3f419fffe02934b6f27b697f7a6401072491ed
ToppCellfacs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FLT1 PTP4A3 ENG RAPGEF4

2.76e-05190414632d5dc11765053366d61f0a0c7916111cea4f50
ToppCellCOVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

FLT1 ASRGL1 ARHGEF10 RAPGEF4

2.76e-051904149fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MFSD4A FLT1 ENG RAPGEF4

2.88e-05192414c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCellfacs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 ATP1A1 ENG RAPGEF4

2.88e-051924144bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCellE15.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FBN2 RFC5 RPL12 TPI1

2.88e-051924144a0fb4ef8a9281489ffb0881421c9d691c52019c
ToppCellLPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MFSD4A FLT1 ENG RAPGEF4

2.88e-0519241404f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCellLPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MFSD4A FLT1 ENG RAPGEF4

2.88e-051924140aeb5351275c0a91151ea2d52b2cdde172da6731
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

FLT1 LTK ARHGEF10 RAPGEF4

2.94e-05193414f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCell3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLT1 ASRGL1 ENG RAPGEF4

2.94e-05193414c0f0052c24b7fe9e21d2bc6c38047a8e755f87b6
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MFSD4A FLT1 ENG RAPGEF4

2.94e-05193414e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLT1 ASRGL1 ENG RAPGEF4

2.94e-05193414682ce63b73a7d02eef240673db67058d7507f744
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 LTK ENG RAPGEF4

2.94e-05193414456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCellLPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MFSD4A FLT1 ENG RAPGEF4

2.94e-051934146e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCellLPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MFSD4A FLT1 ENG RAPGEF4

2.94e-05193414af5108260783e69a7d67896c5bf64f862525926d
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor

FLT1 LTK ENG RAPGEF4

2.94e-0519341439c6c96a2a100b1b290a779d36cc6bc17245720b
ToppCell(6)_Endothelial-C_(Capillary_Aerocyte_)|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

FLT1 LTK ARHGEF10 RAPGEF4

2.94e-05193414f7f2dc6aff02d096a282835094d26d12b3b73e61
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

FLT1 LTK ENG RAPGEF4

3.00e-0519441468004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCellLPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MFSD4A FLT1 ENG RAPGEF4

3.00e-051944140b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCellEndothelial-endothelial_cell_of_vein|World / Lineage, Cell type, age group and donor

FLT1 ASRGL1 ENG RAPGEF4

3.00e-051944143cbd9622a68e89add90e589867d88c83c5a33476
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_vein|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FLT1 ASRGL1 ENG RAPGEF4

3.00e-05194414fc2e0081005c0c496e41197a2d06e4a37708221f
ToppCellfacs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 ATP1A1 ENG RAPGEF4

3.00e-05194414f159ef8541d75a4e98468947f231bb463bec922c
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

FLT1 ASRGL1 ENG RAPGEF4

3.00e-0519441440842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCell3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLT1 ASRGL1 ENG RAPGEF4

3.06e-0519541453b83e16b350100b1d5791a9c42bd98e37cbc0af
ToppCell367C-Endothelial_cells-Endothelial-E|367C / Donor, Lineage, Cell class and subclass (all cells)

MFSD4A FLT1 ENG RAPGEF4

3.06e-051954143b79e6bb525b17192ecec9e1227a29c419968144
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 ASRGL1 ENG RAPGEF4

3.06e-05195414d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell(6)_Endothelial-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

FLT1 ASRGL1 ENG RAPGEF4

3.06e-05195414c0005a5f2dc63a0cc254c45ac89a2f42df6f8bde
ToppCell367C-Endothelial_cells-Endothelial-E-|367C / Donor, Lineage, Cell class and subclass (all cells)

MFSD4A FLT1 ENG RAPGEF4

3.06e-0519541465fc50e3818e902028fc4226070fa57609c66b9c
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 LTK ENG RAPGEF4

3.06e-0519541423ced69fd904f1d4114b1a7f99f4b5f65ea8824b
ToppCellAT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

ATP1A1 RAB17 RPL12 PMM1

3.06e-0519541433f60762f00cd6f4757d8a8d5227141558ac823e
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 ASRGL1 ENG RAPGEF4

3.12e-0519641448b4a9cea97a55190217deaf51bf867608c5a9a7
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 LTK ENG RAPGEF4

3.12e-05196414d323f7dc41380446e5967c69832bea88351a9331
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MFSD4A UQCRFS1 ATP1A1 TPI1

3.12e-051964146cfb45827e70a65d6a81a7bcb305b2dafbbf641f
ToppCellNasal_Brush-Epithelial-Goblet_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

MFSD4A GAN ASRGL1 ELAPOR1

3.12e-05196414e16f0831f1f677b28e4a8014f0aede7e713d4f04
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 ASRGL1 ENG RAPGEF4

3.12e-05196414473980c827443464d08a0be28c53e3536369b12a
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 LTK ENG RAPGEF4

3.12e-0519641465d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 ASRGL1 ENG RAPGEF4

3.12e-051964148f2031b1a9232c389517fbf3c29f47f9468b0077
ToppCellNasal_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

MFSD4A GAN ASRGL1 ELAPOR1

3.12e-0519641471e88d9ca28168732bd91f2d4f8f53bb4187963a
ToppCell5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLT1 ASRGL1 ENG RAPGEF4

3.18e-0519741487eda06344498dc66cac292cf89746dc90b5cf67
ToppCell368C-Endothelial_cells-Endothelial-A_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells)

FLT1 ASRGL1 ENG RAPGEF4

3.18e-051974147caa2c86dc4d50b57a7db8f7278d1588282ad6db
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLT1 ASRGL1 ENG RAPGEF4

3.18e-05197414b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576
ToppCell3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLT1 PTP4A3 ENG RAPGEF4

3.18e-05197414947042f888335c0829d4d5daeb623973eadb3348
ToppCell368C-Endothelial_cells-Endothelial-A_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells)

FLT1 ASRGL1 ENG RAPGEF4

3.18e-05197414951f18f326967206adbbfc422cce9eea3d2e0854
ToppCellBronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLT1 ASRGL1 ENG RAPGEF4

3.18e-0519741481718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCell368C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

FLT1 ASRGL1 ATP1A1 ENG

3.24e-051984146b8baa0b76242736f6dba482cdaad019256877ea
ToppCell3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLT1 LTK ENG ARHGEF10

3.24e-051984149ecf944984aade1bf902e3a92ea4d46a3696822f
ToppCellCOVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

FLT1 ASRGL1 ENG RAPGEF4

3.24e-0519841445419f2804b4be79bae6632e71c54e1af482d115
ToppCell10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FLT1 HERC2 ENG RAPGEF4

3.24e-051984140a4626b51ba8b52acbaf616f0ced850079cd7149
ToppCellTracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

FLT1 ASRGL1 ENG RAPGEF4

3.24e-051984146fd984da5d2c419aeb34c8cbd8a00440e2f820a5
ToppCell368C-Endothelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells)

FLT1 ASRGL1 ENG RAPGEF4

3.24e-051984149a2c2201baee51581733e183065298a97eba4553
ToppCell368C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

FLT1 ASRGL1 ATP1A1 ENG

3.24e-051984148519c7bd5f6c5a97f5e43f4729b1411d3b07e4c8
ToppCell5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLT1 ENG ARHGEF10 RAPGEF4

3.24e-05198414d5990cab01de6e6f3757f5a50ef70ced711bb1fa
ToppCellBronchial-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLT1 ASRGL1 ENG RAPGEF4

3.24e-05198414a1ccbf0e653b2dd665c2254920eb9b37243cc0bd
ToppCellCOVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type

FLT1 ASRGL1 ENG RAPGEF4

3.31e-05199414793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCellNS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MFSD4A ASRGL1 ATP1A1 ELAPOR1

3.31e-0519941432bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCellmedial-2-Endothelial-Artery|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

FLT1 ASRGL1 ATP1A1 ENG

3.31e-0519941453c17c0493f82351a039bc64def191311e0f4951
ToppCellmedial-Endothelial-Artery-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

FLT1 ASRGL1 ATP1A1 ENG

3.31e-05199414c455f5a2802f2ec6f0e24266de1aaf3203ca8c78
ToppCellBronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLT1 ASRGL1 ENG RAPGEF4

3.31e-0519941436a230b80096455df26c2e2c8c05fd6b231508c5
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 LTK ENG RAPGEF4

3.31e-051994145d976d57872a8a25a11fe8cd53b01aa21a1a519a
ToppCellTracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FLT1 ASRGL1 ENG UMODL1

3.31e-051994149735a1dc10910f02f1106b20ae5ab4c09c21305e
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MFSD4A ASRGL1 ATP1A1 ELAPOR1

3.31e-051994146977f939ddbc47d4921f36c0a61a205259fe1284
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLT1 ASRGL1 ENG RAPGEF4

3.31e-05199414e2d5c5cab102e67b0131b02392d81adaedc15965
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MFSD4A UQCRFS1 ATP1A1 TPI1

3.31e-0519941441f3f5df41a142240947d9a57a6a282cba0c7aaa
ToppCellcontrol-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

MFSD4A ASRGL1 ATP1A1 ELAPOR1

3.31e-05199414262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCellcellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

FLT1 ENG ARHGEF10 RAPGEF4

3.31e-051994145f67ea58512856cbdcef759088a5869720a947a8
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLT1 LTK ENG RAPGEF4

3.31e-05199414dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53
ToppCellTracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

FLT1 LTK ENG ARHGEF10

3.31e-051994141621ce2968f3100e4c39e0ef8293232a5d76c614
ToppCellmedial-Endothelial-Artery|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

FLT1 ASRGL1 ATP1A1 ENG

3.31e-05199414341c0be18bec66f4cc8bda232dce54edb34b9cda
Diseaselevel of Sterol ester (27:1/20:4) in blood serum

PBX4 ASRGL1

7.33e-0431382OBA_2045198
Diseasevesicoureteral reflux

ENG ARHGEF10

1.10e-0338382EFO_0007536
Diseasehealth literacy measurement

GAN UQCRFS1

2.14e-0353382EFO_0010104
DiseaseFamilial thoracic aortic aneurysm and aortic dissection

FBN2 ENG

2.14e-0353382C4707243
Diseasepre-eclampsia (is_marker_for)

FLT1 ENG

2.55e-0358382DOID:10591 (is_marker_for)

Protein segments in the cluster

PeptideGeneStartEntry
VKTSYQGCGADVSTT

UMODL1

376

Q5DID0
ICVGTEEGSISIYKS

ARHGEF10

991

O15013
KVFVCGGVTTASDVQ

CCIN

526

Q13939
CKGNVAYATSTGGIV

ASRGL1

176

Q7L266
EVTYTTSQVSKGCVA

ENG

41

P17813
VGSTCDVKVKNGTTY

ATXN2L

131

Q8WWM7
YKSSGTVVLAQCTVE

CPNE6

276

O95741
VGCAFFTKVVDVGAT

RAB17

51

Q9H0T7
YKGCATTVLVTGAGV

MFSD4A

431

Q8N468
VISVVGYTNCGKTTL

GTPBP6

296

O43824
AVTVEGKVYACGEAT

HERC2

3006

O95714
STNCVEGTARGIVVY

ATP1A1

246

P05023
VASGTVIGVVIYTGK

ATP9B

341

O43861
AIVSSCVAGIQKTTY

ELAPOR1

866

Q6UXG2
CDGAYAGTSVVVTVG

LTK

86

P29376
TAGGKKTEEVECLTY

F13B

186

P05160
GVTKGCSLENVYTVS

LAMA2

2516

P24043
VKCAAVGSIVYVLAG

KLHL7

521

Q8IXQ5
IYTGKTAVDTTEVGV

PBX4

281

Q9BYU1
GVDVITEYVKACDGI

ERVK-5

501

Q9HDB9
VSSGVYVCKVVEGTA

HTRA4

406

P83105
YVCKVVEGTAAQSSG

HTRA4

411

P83105
CYVFGTGTKVTVLGQ

IGLL5

96

B9A064
YSECIVTVGGEERVS

GAN

271

Q9H2C0
YSVKKGTTGCTDVDE

FBN2

1356

P35556
EVYVSLGVSVGKCRG

C8B

391

P07358
SVNVVIYGKGVVCTL

RAPGEF4

401

Q8WZA2
CTIRGIETTGKAVYI

SLC6A19

211

Q695T7
AFGKVTEETVYTCTG

RFC5

226

P40937
VQIGVVGGSDYCKIA

PMM1

46

Q92871
VSINCAKTGYSATVI

OSBPL10

611

Q9BXB5
VVYCGAVGTGQAAKI

HIBADH

196

P31937
GYSVCVVEVKVSDSR

VSIG8

246

P0DPA2
GATTVVRVCEVTYDK

PTP4A3

41

O75365
LVTGVTTVGVAYAAK

UQCRFS1

116

P47985
QTVIGIKYCESIESG

ZNF268

241

Q14587
KVVYLRCTGGEVGAT

RPL12

11

P30050
KIYGCDFIVSATGVT

PYROXD1

306

Q8WU10
GDFVKVYSTVTEECV

WDR75

36

Q8IWA0
RIIYGGSVTGATCKE

TPI1

206

P60174
GIYICIASNKVGTVG

FLT1

531

P17948
VKSCESSVYGEVGSA

ZNF433

101

Q8N7K0
IVGVTTEDDGIYTCI

TRIO

2746

O75962